- Home
- Leadership
Leadership
Three directors run Omicron Pharmatech, covering strategy, manufacturing and international compliance.

Samirkumar Mahendraprasad Joshi
Chief Executive Officer and Director
Samirkumar has led Omicron Pharmatech since its incorporation in March 2022, building the export business that now accounts for about 60% of the company’s output.
Responsible for
- Company strategy and international expansion
- Supply partnerships across Asia, Europe and the Americas
- GMP manufacturing framework
- Diversification into pharmaceutical, cosmetic and agricultural markets

Satish Padmanabhan Kunji
Director, Operations
Satish runs manufacturing at the Naroda facility, from capacity planning to batch release, with a focus on lean processes and consistent quality.
Responsible for
- End-to-end manufacturing operations and capacity planning
- Lean manufacturing and process optimisation
- Quality control systems for every batch
- Production and logistics teams

Hareshkumar Jayantilal Patel
Director, Compliance and Trade
Hareshkumar handles regulatory compliance and cross-border trade, and led the company’s entry into the agro-nutrient market.
Responsible for
- International regulatory compliance
- B2B trading frameworks for pharmaceutical and agrochemical sectors
- Relationships with global distributors
- Agro-nutrient business development
Built in Naroda, shipped worldwide
Since March 2022, Omicron Pharmatech has grown from a regional chemical manufacturer into an exporter of APIs, corticosteroids, hormones, excipients and agro nutrients, with about 60% of output going overseas.
Our facility in the Fortune South Industrial Park, Ahmedabad, sits in one of India’s main chemical and pharmaceutical corridors, close to suppliers, skilled people and the ports of Gujarat.
Talk to our team